ONL Q1 2026 Earnings Significant EPS Miss as Losses Widen Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues UGI Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Resilience GNS Q4 2022 Earnings Massive EPS Miss as Reported Loss Exceeds Estimates by Wide Margin Amrize Ltd Ordinary Shares AMRZ Q1 2026 Earnings EPS Misses Estimates Amid Significant Surprise BE Q1 2026 Earnings Impressive EPS Beat Amidst Ongoing Investor Caution